Tag

Age Related Macular Degeneration

All articles tagged with #age related macular degeneration

GLP-1 Weight-Loss Drugs Show Promising Eye Health Benefit in Seniors
health22 days ago

GLP-1 Weight-Loss Drugs Show Promising Eye Health Benefit in Seniors

A study of more than 157,000 obese adults without diabetes found GLP-1 receptor agonists (used for weight loss) are linked to an about 18% lower risk of developing age-related macular degeneration (AMD), rising to around 30% in unspecified AMD cases. The protective effect may stem from weight loss reducing systemic inflammation and oxidative stress, but the study is observational and short–term, so it cannot establish causation or mechanism. More research is needed to determine whether GLP-1s offer retinal protection or if weight loss itself drives the benefit.

Diabetes Drug Metformin Linked to Slower Age-Related Vision Loss
health6 months ago

Diabetes Drug Metformin Linked to Slower Age-Related Vision Loss

A Liverpool study of about 2,000 adults with diabetes aged 50+ found that those taking metformin had 37% lower odds of developing intermediate age-related macular degeneration (AMD) over five years compared with non-users, suggesting metformin might help slow age-related vision loss. However, researchers caution that the findings are observational and do not prove causation or support using metformin to treat AMD outside of diabetes; clinical trials are needed to confirm any benefit.

DNA Damage: A Crucial Factor in Macular Degeneration
health1 year ago

DNA Damage: A Crucial Factor in Macular Degeneration

Researchers have identified accumulated DNA damage in the retina as a key factor in age-related macular degeneration (AMD), a leading cause of blindness in people over 50. The study, published in Aging Cell, suggests that targeting specific retinal cells could lead to treatments that slow or stop AMD progression. The research highlights the importance of DNA repair in maintaining retinal health and suggests potential interventions to counteract oxidative stress and enhance DNA repair. The study involved collaboration from multiple universities and was supported by various foundations and the NIH.

"Revolutionizing Retinal Imaging: AI Speeds Up Process 100-Fold"
healthtech2 years ago

"Revolutionizing Retinal Imaging: AI Speeds Up Process 100-Fold"

Researchers at the National Institutes of Health have utilized artificial intelligence (AI) to significantly improve the speed and quality of retinal imaging, making it 100 times faster and enhancing image contrast 3.5-fold. By integrating AI with adaptive optics optical coherence tomography (OCT), the new method, called parallel discriminator generative adverbial network (P-GAN), successfully de-speckles retinal pigment epithelium (RPE) images, providing a better tool for evaluating age-related macular degeneration and other retinal diseases. This advancement is expected to make AO imaging more accessible for routine clinical applications and studies aimed at understanding blinding retinal diseases.

"Revolutionary Solar-Powered Eye Implants: Restoring Vision with Self-Powered Bionics"
healthtech2 years ago

"Revolutionary Solar-Powered Eye Implants: Restoring Vision with Self-Powered Bionics"

Researchers have developed solar-powered eye implants that could potentially help people with incurable eye diseases such as retinitis pigmentosa and age-related macular degeneration. The technology aims to power sensors and cameras in the eye using solar photovoltaic panels, eliminating the need for external charging. While still in the proof-of-concept stage, the idea shows promise in addressing the challenge of powering the implants and could significantly impact the treatment of eye diseases in the future.

"Florida's Eye Degeneration Epidemic: New Drugs Offer Hope for Vision Preservation"
health3 years ago

"Florida's Eye Degeneration Epidemic: New Drugs Offer Hope for Vision Preservation"

Age-related macular degeneration (AMD) is a leading cause of irreversible blindness and visual impairment, affecting one in 10 Americans aged 50 and above. While effective drugs have been developed to preserve vision, Florida has the highest rate of AMD in the US, partly due to its higher elderly population. Smoking and genetics are also risk factors for the disease, which predominantly affects Caucasians. Regular eye exams are crucial for early detection, as early onset has few symptoms. The FDA recently approved medications for the dry form of AMD, and injections directly into the eyeball have shown promising results in preventing the growth of abnormal blood vessels. Education on the importance of eye exams and early diagnosis remains a concern, as many adults have not had an eye exam in years.

"Age-Related Vision Issues and Common Eye Hazards: What You Need to Know"
health3 years ago

"Age-Related Vision Issues and Common Eye Hazards: What You Need to Know"

Aging can lead to various vision problems, including presbyopia (age-related farsightedness), age-related macular degeneration (AMD), dry eyes, glaucoma, cataracts, and other changes in sight. These conditions can cause difficulties in seeing things up close, distinguishing colors, and peripheral vision loss. Regular eye exams, lifestyle adjustments, and treatments such as eyeglasses, surgery, and supplements can help manage and prevent further vision problems associated with aging.

"5 Daily Habits to Safeguard Your Vision"
health3 years ago

"5 Daily Habits to Safeguard Your Vision"

Age-related macular degeneration (AMD) is the top cause of vision loss in people over 50, but there are habits that can help reduce the risk of developing AMD and keep vision sharp as you age. These habits include drinking green smoothies, getting enough sleep, consuming carotenoids found in fruits and veggies, savoring 'golden milk', and considering medical treatment.

New Drugs Discovered for Treating Age-Related Macular Degeneration and Other Diseases.
health3 years ago

New Drugs Discovered for Treating Age-Related Macular Degeneration and Other Diseases.

Researchers have discovered small-molecule drugs called stress resilience-enhancing drugs (SREDs) that could be used to treat age-related macular degeneration, diabetic retinopathy, and retinitis pigmentosa. The drugs slowed or halted the progression of retinopathies in animal models by inhibiting cyclic nucleotide phosphodiesterases. These chronic, progressive retinal diseases arise from genetic and environmental disruptions of cellular and tissue stability, and currently have limited treatment options. The researchers innovated a systems pharmacology platform that leverages state-of-the-art disease modeling and characterization to identify novel, mechanism-based therapies that mitigate disease at the root cause.

Causal genes for age-related macular degeneration identified in new study.
health3 years ago

Causal genes for age-related macular degeneration identified in new study.

A study led by Genentech has identified 23 significant genome-wide loci that are differentially methylated in age-related macular degeneration (AMD), a condition that can result in blindness. The research highlights causal gene upregulations and underlying genetic risks for AMD. The study also found different clusters of Müller glia cell states, which could be crucial for retinal regeneration research. The researchers dispelled previous assumptions and identified a robust number of relevant gene mechanisms related to AMD that will likely form the basis for future research on the subject.